Selective maternal inheritance of risk alleles and genetic interaction between serotonin receptor-1B (5-HTR1B) and serotonin transporter (SLC6A4) in ADHD

Psychiatry Research

Volumn 200, Issue 2-3, 2012, Pages 1083-1085

  Banerjee, Emili ^a,b   Banerjee, Disha ^a,b   Chatterjee, Anindita ^b   Sinha, Swagata ^b   Nandagopal, Krishnadas ^a,b  

^a Manovikas Biomedical Research and Diagnostic Centre   (India)

^b Manovikas Kendra Rehabilitation and Research Institute for the Handicapped   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN 1B RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ATTENTION DEFICIT DISORDER; DSM-IV; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SCREENING; HUMAN; LETTER; MOLECULAR PATHOLOGY; NONHUMAN; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEROTONIN 1B RECEPTOR GENE; SEROTONIN TRANSPORTER GENE; SEROTONINERGIC TRANSMISSION; SEX DIFFERENCE;

ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; RECEPTOR, SEROTONIN, 5-HT1B; RISK; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84872394647     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.04.003     Document Type: Letter

References (31)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth ed. Text Revised (DSM-IV TR 2000). American Psychiatric Association Press, Washington DC, pp. 1158-1170.
2. Anney R.J., Hawi Z., Sheehan K., Mulligan A., Pinto C., Brookes K.J., Xu X., Zhou K., Franke B., Buitelaar J., Vermeulen S.H., Banaschewski T., Sonuga-Barke E., Ebstein R., Manor I., Miranda A., Mulas F., Oades R.D., Roeyers H., Rommelse N., Rothenberger A., Sergeant J., Steinhausen H.C., Taylor E., Thompson M., Asherson P., Faraone S.V., Gill M. Parent of origin effects in attention/deficit hyperactivity disorder (ADHD): analysis of data from the international multicenter ADHD genetics (IMAGE) program. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B(8):1495-1500.
3. Banerjee E., Sinha S., Gangopadhyay P.K., Chatterjee A., Singh M., Nandagopal K. A family-based study of Indian subjects from Kolkata reveals allelic association of the Serotonin transporter intron-2 (STin2) polymorphism and Attention-Deficit-Hyperactivity disorder (ADHD). American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2006, 141B:361-366.
4. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., Mössner R., Westphal H., Lesch K.P. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylene-dioxymethamphetamine (Ecstasy) in serotonin transporter-deficient mice. Molecular Pharmacology 1998, 53(4):649-655.
5. Bouwknecht J.A., Hijzen T.H., van der Gugten J., Mass R.A.A., Hen R., Olivier B. Absence of 5HTR-1B receptors is associated with impaired impulse control in male 5HTR-1B knockout mice. Biological Psychiatry 2001, 49:557-568.
6. Coleman M. Serotonin concentrations in whole blood of hyperactive children. The Journal of Pediatrics 1971, 78:985-990.
7. Conners C.K. Rating scales in attention deficit/hyperactivity disorder: use in assessment and treatment monitoring. Journal of Clinical Psychiatry 1998, 59:24-30.
8. Daubert E.A., Condron B.G. Serotonin: a regulator of neuronal morphology and circuitry. Trends in Neurosciences 2010, 33(9):424-434.
9. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., Sklar P. Molecular genetics of attention-deficit hyperactivity disorder. Biological Psychiatry 2005, 57(11):1313-1323.
10. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999, 283:397-401.
11. Gizer I.R., Ficks C., Waldman I.D. Candidate gene studies of ADHD: a meta-analytic review. Human Genetics 2009, 126(1):51-90.
12. Hawi Z., Dring M., Kirley A., Foley D., Kent L., Craddock N., Asherson P., Curran S., Gould A., Richards S., Lawson D., Pay H., Turic D., Langley K., Owen M., O'Donovan M, Thapar A, Fitzgerald M, Gill M. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HTR(1B) receptor gene in 273 nuclear families from a multi-centre sample. Molecular Psychiatry 2002, 7(7):718-725.
13. Ickowicz A., Feng Y., Wigg K., Quist J., Pathare T., Roberts W., Malone M., Schachar R., Tannock R., Kennedy J.L., Barr C.L. The serotonin receptor HTR1B: gene polymorphisms in attention deficit hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007, 144B(1):121-125.
14. Jin H., Oksenberg D., Ashkenazi A., Peroutka S.J., Duncan A.M., Rozmahel R., Yang Y., Mengod G., Palacios J.M., O'Dowd B.F. Characterization of the human 5-hydroxytryptamine-1B receptor. The Journal of Biological Chemistry 1992, 267(9):5735-5738.
15. Kalueff A.V., Fox M.A., Gallagher P.S., Murphy D.L. Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes, Brain, and Behavior 2007, 6(4):389-400.
16. Kim J.W., Waldman I.D., Faraone S.V., Biederman J., Doyle A.E., Purcell S., Arbeitman L., Fagerness J., Sklar P., Smoller J.W. Investigation of parent-of-origin effects in ADHD candidate genes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007, 144B(6):776-780.
17. Laurin N., Feng Y., Ickowicz A., Pathare T., Malone M., Tannock R., Schachar R., Kennedy J.L., Barr C.L. No preferential transmission of paternal alleles at risk genes in attention-deficit hyperactivity disorder. Molecular Psychiatry 2007, 12(3):226-229.
18. Mahmoudi-Gharaei J., Dodargi N., Tehrani-Doost M., Faghihi T. Duloxetine in the treatment of adolescents with attention deficit hyperactivity disorder: an open label study. Human Psychopharmacology 2011, 26(2):155-160.
19. Ma D.Q., Whitehead P.L., Menold M.M., Martin E.R., Ashley-Koch A.E., Mei H., Ritchie M.D., DeLong G.R., Abramson R.K., Wright H.H., Cuccaro M.L., Hussman J.P., Gilbert J.R., Pericak-Vance.M.A. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. American Journal of Human Genetics 2005, 77:377-388.
20. Mei H., Cuccaro M.L., Martin E.R. Multifactor dimensionality reduction-phenomics: a novel method to capture genetic heterogeneity with use of phenotypic variables. American Journal of Human Genetics 2007, 81(6):1251-1261.
21. Ogdie M.N., Macphie I.L., Minassian S.L., Yang M., Fisher S.E., Francks C., Cantor R.M., McCracken J.T., McGough J.J., Nelson S.F., Monaco A.P., Smalley S.L. A genome-wide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. American Journal of Human Genetics 2003, 72(5):1268-1279.
22. Ogdie M.N., Fisher S.E., Yang M., Ishii J., Francks C., Loo S.K., Cantor R.M., McCracken J.T., McGough J.J., Smalley S.L., Nelson S.F. Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. American Journal of Human Genetics 2004, 75(4):661-668.
23. Ortiz J., Artigas F., Gelpi E. Serotonergic status in human blood. Life Sciences 1988, 43:983-990.
24. Pliszka S.R. Non-stimulant treatment of attention-deficit/hyperactivity disorder. CNS Spectrums 2003, 8(4):253-258.
25. Quist J.F., Kennedy J.L. Genetics of childhood disorders: XXIII. ADHD, part 7: the serotonin system. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40:253-257.
26. Shanahan N.A., Holick-Pierz K.A., Masten V.L., Waeber C., Ansorge M., Gingrich J.A., Geyer M.A., Hen R., Dulawa S.C. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice. Biological Psychiatry 2009, 65(5):401-408.
27. Smoller J.W., Biederman J., Arbeitman L., Doyle A.E., Fagerness J., Perlis R.H., Sklar P., Faraone S.V. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biological Psychiatry 2005, 56:665-669.
28. Spielman R.S., Ewens W.J. The TDT and other family-based tests for linkage disequilibrium and association. American Journal of Human Genetics 1996, 59:983-989.
29. Stoltenberg S.F. Epistasis among presynaptic serotonergic system components. Behavior Genetics 2005, 35(2):199-209.
30. Terwilliger J, Ott J. A haplotype-based haplotype relative risk approach to detecting allelic association. Human Heredity 1992, 42:337-346.
31. Vasiliou S.A., Ali F.R., Haddley K., Cardoso M.C., Bubb V.J., Quinn J.P. The SLC6A4 VNTR genotype determines transcription factor binding and epigenetic variation of this gene in response to cocaine in vitro. Addiction Biology 2012, 17:156-170.